1. Home
  2. KRYS vs GSAT Comparison

KRYS vs GSAT Comparison

Compare KRYS & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • GSAT
  • Stock Information
  • Founded
  • KRYS 2015
  • GSAT 2003
  • Country
  • KRYS United States
  • GSAT United States
  • Employees
  • KRYS N/A
  • GSAT N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • GSAT Telecommunications Equipment
  • Sector
  • KRYS Health Care
  • GSAT Consumer Discretionary
  • Exchange
  • KRYS Nasdaq
  • GSAT Nasdaq
  • Market Cap
  • KRYS 4.3B
  • GSAT 3.9B
  • IPO Year
  • KRYS 2017
  • GSAT 2006
  • Fundamental
  • Price
  • KRYS $155.71
  • GSAT $31.17
  • Analyst Decision
  • KRYS Strong Buy
  • GSAT Strong Buy
  • Analyst Count
  • KRYS 9
  • GSAT 3
  • Target Price
  • KRYS $203.22
  • GSAT $43.33
  • AVG Volume (30 Days)
  • KRYS 295.3K
  • GSAT 1.2M
  • Earning Date
  • KRYS 11-03-2025
  • GSAT 11-06-2025
  • Dividend Yield
  • KRYS N/A
  • GSAT N/A
  • EPS Growth
  • KRYS 36.22
  • GSAT N/A
  • EPS
  • KRYS 4.91
  • GSAT N/A
  • Revenue
  • KRYS $359,205,000.00
  • GSAT $260,664,000.00
  • Revenue This Year
  • KRYS $34.33
  • GSAT $7.93
  • Revenue Next Year
  • KRYS $47.84
  • GSAT $18.95
  • P/E Ratio
  • KRYS $31.68
  • GSAT N/A
  • Revenue Growth
  • KRYS 116.08
  • GSAT 14.85
  • 52 Week Low
  • KRYS $122.80
  • GSAT $15.00
  • 52 Week High
  • KRYS $207.84
  • GSAT $41.10
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 60.39
  • GSAT 55.33
  • Support Level
  • KRYS $136.73
  • GSAT $29.36
  • Resistance Level
  • KRYS $152.96
  • GSAT $40.56
  • Average True Range (ATR)
  • KRYS 5.13
  • GSAT 2.33
  • MACD
  • KRYS 0.11
  • GSAT -0.06
  • Stochastic Oscillator
  • KRYS 97.23
  • GSAT 31.86

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: